Clean Yield Group Neu Base Therapeutics, Inc. Transaction History

Clean Yield Group

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 27, 2021	SELL	$3.27 - $4.76 $10,137 - $14,756	-3,100 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$4.63 - $7.34 $14,353 - $22,754	3,100 New	3,100 $15,000
Q1 2021 Apr 26, 2021	SELL	$6.92 - $12.36 $21,452 - $38,316	-3,100 Closed	0 $0
Q4 2020 Jan 26, 2021	BUY	$6.92 - $9.25 $21,452 - $28,675	3,100 New	3,100 $22,000

Ticker NBSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,258,700
Description
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...

Get notified when there are updates to the investment portfolio of Clean Yield Group, based on Form 13F filings with the SEC.

Stay updated on Clean Yield Group with notifications on news.